logo

For the Inventor, By the Inventor

Cheongju-si, South Korea

Chun Sik Kim

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Cheongju-si, KR (2018 - 2019)
  • Cheonju-si, KR (2021)

Company Filing History:

goldMedal3 out of 43 
 
Chungbuk National University Industry-Academic Cooperation Foundation
 patents

Years Active: 2018-2021

Loading Chart...
3 patents (USPTO):Explore Patents
1. 10918609 - Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient (2021-02-16),
2. 10265276 - Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient (2019-04-23),
3. 10125073 - 2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol and preparation method therefor (2018-11-13),

Title: Chun Sik Kim: Pioneering Female Inventor from Cheongju-si, South Korea

Introduction: Chun Sik Kim is a trailblazing inventor hailing from Cheongju-si, South Korea, known for her innovative contributions to various fields.

Latest Patents: Chun Sik Kim holds several patents in the areas of technology and healthcare, showcasing her versatility and creativity in inventing new solutions.

Career Highlights: Throughout her illustrious career, Chun Sik Kim has been recognized for her groundbreaking inventions that have significantly impacted industries such as robotics, biotechnology, and sustainable energy.

Collaborations: Chun Sik Kim has collaborated with leading research institutions and universities worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Chun Sik Kim's dedication to pushing the boundaries of innovation and her commitment to creating a positive impact on society solidify her legacy as a pioneering female inventor in the global landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…